Carisma Therapeutics Current Cash

Carisma Therapeutics (CARM) currently reports a current cash of $2.8M as of September 2025. That compares with $27M in the prior-year period — down 89.7% year over year. Use the charts on this page to explore Carisma Therapeutics's current cash history and peer comparisons.

Carisma Therapeutics's current cash decreased from $27M to $2.8M — a 89.7% year-over-year decrease (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Carisma Therapeutics reported $2.8M in current cash as of September 2025. That compares with $27M in the prior-year period — down 89.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $2.8M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Carisma Therapeutics, and consider following CARM for alerts when major investors trade the stock.

Carisma Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $2.8M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CARM with unrelated industries.